FUSCO, Ferdinando
 Distribuzione geografica
Continente #
EU - Europa 6.607
AS - Asia 3.315
NA - Nord America 2.356
SA - Sud America 781
AF - Africa 72
Continente sconosciuto - Info sul continente non disponibili 1
OC - Oceania 1
Totale 13.133
Nazione #
RU - Federazione Russa 4.975
US - Stati Uniti d'America 2.317
SG - Singapore 1.398
IE - Irlanda 860
HK - Hong Kong 729
BR - Brasile 672
CN - Cina 519
GB - Regno Unito 315
VN - Vietnam 291
IT - Italia 162
KR - Corea 157
GR - Grecia 70
DE - Germania 66
IN - India 48
AR - Argentina 34
JP - Giappone 30
EC - Ecuador 25
ID - Indonesia 24
SE - Svezia 24
FR - Francia 23
SC - Seychelles 23
UA - Ucraina 23
TR - Turchia 21
IQ - Iraq 20
BD - Bangladesh 19
AT - Austria 18
FI - Finlandia 18
NL - Olanda 17
CO - Colombia 16
MX - Messico 16
CA - Canada 12
ZA - Sudafrica 11
PY - Paraguay 10
TH - Thailandia 10
MA - Marocco 9
VE - Venezuela 8
CL - Cile 7
PE - Perù 7
PK - Pakistan 7
DZ - Algeria 6
EG - Egitto 6
PL - Polonia 6
TN - Tunisia 6
UZ - Uzbekistan 6
ES - Italia 5
MY - Malesia 5
AL - Albania 4
BE - Belgio 4
CZ - Repubblica Ceca 4
JO - Giordania 4
SA - Arabia Saudita 4
AZ - Azerbaigian 3
BG - Bulgaria 3
DO - Repubblica Dominicana 3
IL - Israele 3
PH - Filippine 3
AE - Emirati Arabi Uniti 2
CI - Costa d'Avorio 2
HR - Croazia 2
JM - Giamaica 2
KE - Kenya 2
KG - Kirghizistan 2
KH - Cambogia 2
PA - Panama 2
TW - Taiwan 2
UY - Uruguay 2
AU - Australia 1
BA - Bosnia-Erzegovina 1
BF - Burkina Faso 1
BH - Bahrain 1
BW - Botswana 1
BY - Bielorussia 1
CG - Congo 1
DK - Danimarca 1
GA - Gabon 1
GT - Guatemala 1
HT - Haiti 1
HU - Ungheria 1
IM - Isola di Man 1
IR - Iran 1
KW - Kuwait 1
KZ - Kazakistan 1
LT - Lituania 1
ML - Mali 1
NI - Nicaragua 1
NP - Nepal 1
PT - Portogallo 1
QA - Qatar 1
SK - Slovacchia (Repubblica Slovacca) 1
SN - Senegal 1
SV - El Salvador 1
XK - ???statistics.table.value.countryCode.XK??? 1
ZW - Zimbabwe 1
Totale 13.133
Città #
Moscow 1.807
Dublin 860
Hong Kong 725
Singapore 525
Santa Clara 524
San Jose 308
Seoul 153
Princeton 144
Roxbury 140
Ashburn 126
Medford 110
Ho Chi Minh City 106
Chandler 104
New York 71
Hanoi 67
São Paulo 62
Beijing 61
The Dalles 55
Hefei 50
Wilmington 50
Des Moines 41
Naples 40
Orem 38
Cambridge 33
Jacksonville 31
Council Bluffs 23
Rio de Janeiro 20
Bengaluru 18
Munich 18
Haiphong 17
Los Angeles 17
Jinan 16
Salerno 16
Falkenstein 15
Belo Horizonte 14
Dallas 14
Campinas 12
Curitiba 12
Da Nang 12
Guangzhou 11
Norwalk 11
Ercolano 10
Frankfurt am Main 10
Amsterdam 9
Brasília 9
Guayaquil 9
Helsinki 9
Lusciano 9
Santo André 9
Bangkok 8
Biên Hòa 8
Boardman 8
Boston 8
Chennai 8
Rome 8
Vienna 8
Atlanta 7
Bogotá 7
Caserta 7
Falls Church 7
Guarulhos 7
Jakarta 7
Mexico City 7
Porto Alegre 7
Quito 7
Shanghai 7
Baghdad 6
Dhaka 6
Goiânia 6
Hải Dương 6
Milan 6
Nanjing 6
Nuremberg 6
Ribeirão Preto 6
Salvador 6
Seattle 6
Taizhou 6
Tashkent 6
Bremen 5
Brooklyn 5
Changsha 5
Jiaxing 5
London 5
Maceió 5
Manaus 5
Mauá 5
Pelotas 5
Phoenix 5
Stockholm 5
Taiyuan 5
Amman 4
Asunción 4
Betim 4
Cairo 4
Campos dos Goytacazes 4
Carapicuíba 4
Chicago 4
Columbus 4
Dalian 4
Diadema 4
Totale 6.849
Nome #
Male Sexual Dysfunction and Infertility in Spinal Cord Injury Patients: State-of-the-Art and Future Perspectives 254
COVID-19 Quarantine Dramatically Affected Male Sexual Behavior: Is There a Possibility to Go Back to Normality? 142
[Impact of preoperative therapy with 5-α-reductase inhibitors in the treatment of benign prostatic hyperplasia] 140
Biparametric 3T Magentic Resonance Imaging for prostatic cancer detection in a biopsy-naïve patient population: a further improvement of PI-RADS v2? 140
Bipolar endoscopic enucleation versus bipolar transurethral resection of the prostate: an ESUT systematic review and cumulative analysis 138
Clinical Efficacy of Silodosin in Patients with Severe Lower Urinary Tract Symptoms Related to Benign Prostatic Obstruction: A Pooled Analysis of Phase 3 and 4 Trials 135
Demographic and comorbidity profile of patients with lower urinary tract symptoms suggestive of benign prostatic hyperplasia in a real-life clinical setting: Are 5-alpha-reductase inhibitor consumers different? 131
A report from a single institute's 14-year experience in treatment of male-to-female transsexuals 131
Escherichia coli Nissle 1917 as adjuvant therapy in patients with chronic bacterial prostatitis: a non-blinded, randomized, controlled trial 129
[Tadalafil versus sildenafil citrate in the treatment of ED:Italian patients' preferences and explanatory notes] 128
A new era in the treatment of erectile dysfunction: chronic phosphodiesterase type 5 inhibition 122
Does physical activity regulate prostate carcinogenesis and prostate cancer outcomes? A narrative review 118
Emerging minimally invasive transurethral treatments for benign prostatic hyperplasia: a systematic review with meta-analysis of functional outcomes and description of complications 117
Advances in Urinary Diversion: From Cutaneous Ureterostomy to Orthotopic Neobladder Reconstruction—A Comprehensive Review 116
A new Procedure for Penile Biopsy 116
A case of incidentally discovered solitary fibrous tumor of the kidney: A case study 116
Voice Assistants as Consultants for Male Patients with Sexual Dysfunction: A Reliable Option? 114
Sphingosine 1-Phosphate Induces Endothelial Nitric-Oxide Synthase Activation through Phosphorylation in Human Corpus Cavernosum 114
Hydrogen sulfide as a mediator of human corpus cavernosum smooth-muscle relaxation 114
AESTHETIC NEO-GLANS RECONSTRUCTION FOLLOWING PENIS-SPARING SURGERY FOR BENIGN, PREMALIGNANT OR MALIGNANT PENILE LESIONS 113
[An alternative dosing regimen with tadalafil 3 times/week in the treatment of erectile dysfunction:italian data from the SURE study] 113
Interrelatedness of Urological Conditions and Anal Incontinence 112
Sexual Dysfunction in Patients With Chronic Gastrointestinal and Liver Diseases: A neglected Issue 112
Prostatic high-resolution micro-ultrasound: an attractive step-forward in the management of prostate cancer patients 108
Detrusor overactivity and underactivity: implication for lower urinary tract symptoms related to benign prostate hyperplasia diagnosis and treatment 106
Cognitive Targeted Prostate Biopsy Alone for Diagnosing Clinically Significant Prostate Cancer in Selected Biopsy-Naïve Patients: Results from a Retrospective Pilot Study 105
Three-dimensional vs standard laparoscopy: comparative assessment using a validated program for laparoscopic urologic skills 105
A rare case of male pelvic squamous cell carcinoma of unknown primary origin presenting as perineal abscess and urethral stenosis 105
Rezūm water vapor therapy vs. thulium laser enucleation for the treatment of benign prostatic hyperplasia in patients with large prostates: a multicenter prospective comparative study 103
Aesthetic neo-glans reconstruction after penis-sparing surgery for benign, premalignant or malignant penile lesions 103
A new therapeutic approach to erectile dysfunction: Urotensin-II receptor high affinity agonist ligands 102
A case of highly aggressive anaplastic seminoma of the testis presenting as fungating scrotal lesion 101
A return to love without worry 100
Correlation between detrusor collagen content and urinary symptoms in patients with prostatic obstruction 99
Hyperbaric oxygen therapy reduces mortality in patients with Fournier's Gangrene. Results from a multi-institutional observational study 99
Alpha-1 adrenergic antagonists, 5-alpha reductase inhibitors, phosphodiesterase type 5 inhibitors, and phytotherapic compounds in men with lower urinary tract symptoms suggestive of benign prostatic obstruction: A systematic review and meta-analysis of ur 99
Functional and oncological outcomes after radical prostatectomy in patients with history of surgery for lower urinary tract symptoms related to benign prostatic enlargement: A systematic review with meta-analysis 98
A standardized procedure for using human corpus cavernosum strips to evaluate drug activity 98
Silodosin 8 mg improves benign prostatic obstruction in Caucasian patients with lower urinary tract symptoms suggestive of benign prostatic enlargement: results from an explorative clinical study 98
A new Validated questionnaire in the clinical evaluation of female sexual dysfunction . An italian proposal 98
A new biopsy technique to investigate Peyronie's disease associated histologic alterations: results with two different forms of therapy 97
A First Prospective, Randomized, Double-Blind, Placebo-Controlled Clinical Trial Evaluating Extracorporeal Shock Wave Therapy for the Treatment of Peyronie's Disease 97
The evolving landscape of renal surgery for complex renal masses (CRM): implications for oncologic and functional outcomes 96
Complications and quality of life in elderly patients with several comorbidities undergoing cutaneous ureterostomy with single stoma or ileal conduit after radical cystectomy 93
A survey on the experience of 136 Italian urologists in the treatment of erectile dysfunction with PDE5 inhibitors and recommendations for the use of Avanafil in the clinical practice 93
Metastasis-Directed Radiation Therapy with Consolidative Intent for Oligometastatic Urothelial Carcinoma: A Systematic Review and Meta-Analysis 92
Second cycle of intralesional Collagenase Clostridium histolyticum for Peyronie's disease using the modified shortened protocol: Results from a retrospective analysis 92
Pelvic floor and sexual male dysfunction 92
How radical prostatectomy procedures have changed over the last 10 years in Italy: a comparative analysis based on more than 1500 patients participating in the MIRROR-SIU/LUNA and the Pros-IT CNR study 92
PSA-density does not improve bi-parametric prostate MR detection of prostate cancer in a biopsy naïve patient population 91
Hyperbaric oxygen therapy as adjuvant treatment for surgical site infections after male-to-female gender affirmation surgery: A 10-year experience 90
UROTENSIN II AS A POSSIBLE SERUM MARKER OF ERECTILE DYSFUNCTION 88
Recent advances in percutaneous lithotripsy techniques 87
Hexaminolevulinate blue light cystoscopy (Hal) assisted transurethral resection of the bladder tumour vs white light transurethral resection of the bladder tumour in non-muscle invasive bladder cancer (NMIBC): A retrospective analysis 86
Endovascular therapy for erectile dysfunction: a state of the art review 86
Differential in vivo urodynamic measurement in a single thin catheter based on two optical fiber pressure sensors 86
Diagnostic accuracy of three tesla biparametric magnetic resonance imaging of the prostate, prostate specific antigen density and their combination for the detection of clinically significant prostate cancer: Results from a retrospective study 83
Radical Perineal Prostatectomy versus Radical Retropubic Prostatectomy after Previous Prostate Surgery: Surgical and Functional Outcomes 83
BPH/LUTS and ED: Common Pharmacological Pathways for a Common Treatment 83
Androgens and morphologic remodeling at penile and cardiovascular levels: a common piece in complicated puzzles? 83
Phosphodiesterase Type 5 (PDE5) Inhibitors in Erectile Dysfunction: The Proper Drug for the Proper Patient 83
Efficacy and safety of ciprofloxacin XR 1000 mg once daily versus ciprofloxacin 500 mg twice daily in the treatment of complicated urinary tract infections 82
Sildenafil Effect on the Human Bladder Involves the L-cysteine/Hydrogen Sulfide Pathway: A Novel Mechanism of Action of Phosphodiesterase Type 5 Inhibitors 81
Sperm recovery and ICSI outcomes in men with non-obstructive azoospermia: A systematic review and meta-analysis 81
Donor and recipient outcomes following robotic-assisted laparoscopic living donor nephrectomy: A systematic review 80
Evaluation of an alternative dosing regimen with tadalafil, three times per week, for men with erectile dysfunction: SURE study in Italy 80
Female Sexual Arousal disorders: Our Experience in a oral Treatment 79
Flexible-dose vardenafil in a community-based population of men affected by erectile dysfunction: a 12-week open-label, multicenter trial 79
β3 adrenergic receptor activation relaxes human corpus cavernosum and penile artery through a hydrogen sulfide/cGMP-dependent mechanism 79
EFFICACY AND SAFETY OF CIPROFLOXACIN XR 1000 MG ONCE DAILY VERSUS CIPROFLOXACIN 500 MG TWICE DAILY IN THE TREATMENT OF COMPLICATED URINARY TRACT INFECTIONS 79
Androgens exert direct neuroprotective effects on the brain: A review of pre-clinical evidences 78
Dapoxetine treatment in patients with lifelong premature ejaculation: The reasons of a "waterloo" 78
Prostate Cancer Diagnosis, Treatment and Outcomes in Patients with Previous or Synchronous Colorectal Cancer: A Systematic Review of Published Evidence 77
Trans obturator tape (TOT) procedure for stress urinary incontinence: Results at 4 years follow-up 77
Androgens and benign prostatic hyperplasia 77
Mobile health: a promising tool for the management of male patients with lower urinary tract symptoms suggestive of benign prostatic hyperplasia 77
TADALAFIL ONCE DAILY AND EXTRACORPOREAL SHOCK WAVE THERAPY IN THE MANAGEMENT OF PATIENTS WITH PEYRONIE'S DISEASE AND ERECTILE DYSFUNCTION. RESULTS FROM A PROSPECTIVE RANDOMIZED TRIAL 76
SEXUAL LIFE AND PATIENT SATISFACTION FOLLOWING PENIS-SPARING SURGERY FOR BENIGN, PREMALIGNANT OR MALIGNANT PENILE LESIONS 76
Pharmaco-prothesis: How, when and why? Injection technique 76
Detection of Extraprostatic Extension of Cancer on Biparametric MRI Combining Texture Analysis and Machine Learning: Preliminary Results 76
Impact of Circadian Desynchrony on Spermatogenesis: A Mini Review 76
“Efficacy of a new treatment of premature ejaculation” 75
Tadalafil and vardenafil vs sildenafil: a review of patient-preference studies 75
Ejaculatory Abstinence Influences Intravaginal Ejaculatory Latency Time: Results from a Prospective Randomized Trial 75
Tadalafil once daily and extracorporeal shock wave therapy in the management of patients with Peyronie's disease and erectile dysfunction: Results from a prospective randomized trial 75
Vardenafil for the treatment of erectile dysfunction 74
the detrusor muscle: an innocent victim of bladder outlet obstruction 74
Characteristics of phosphate-1-sphingosin receptors in human corpus cavernosum: cross-talk with eNOS and caveoline-1 74
Virtue male sling for post-prostatectomy stress incontinence: a prospective evaluation and mid-term outcomes 74
Witch is the role played by Extra Shock Waves Treatment in Peyronie disease? 73
Anterior urethroplasty and effects on sexual life: Which is the best technique? 73
Reply to Wael Agur and Jawad Freites’ Letter to the Editor re: Ferdinando Fusco, Mohamed Abdel-Fattah, Christopher R. Chapple, et al. Updated Systematic Review and Meta-analysis of the Comparative Data on Colposuspensions, Pubovaginal Slings, and Midurethral Tapes in the Surgical Treatment of Female Stress Urinary Incontinence. Eur Urol 2017;72:567–91 73
PHASE II MULTICENTRIC STUDY OF SUNITINIB IN METASTATIC RENAL CELL CARCINOMA (MRCC) WITH A POOR PROGNOSIS REFRACTORY TO IMMUNOTHERAPY 72
Benign Prostatic Obstruction Relief in Patients with Lower Urinary Tract Symptoms Suggestive of Benign Prostatic Enlargement Undergoing Endoscopic Surgical Procedures or Therapy with Alpha-Blockers: A Review of Urodynamic Studies 72
Updated Systematic Review and Meta-analysis of the Comparative Data on Colposuspensions, Pubovaginal Slings, and Midurethral Tapes in the Surgical Treatment of Female Stress Urinary Incontinence 72
Short- and Long-Term Evaluation of Renal Function after Radical Cystectomy and Cutaneous Ureterostomy in High-Risk Patients 72
Toxicity of antioxidant supplements in patients with male factor infertility: A systematic review and meta-analysis of randomized controlled trials 72
Prevalence and risk factors of erectile dysfunction in patients with hepatitis B virus or hepatitis C virus or chronic liver disease: Results from a prospective study 71
Hydrogen sulphide as a mediator of penile erection 71
The Urothelium, the urinary microbioma and men LUTS: a systematic review 71
Totale 9.517
Categoria #
all - tutte 51.074
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 51.074


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202183 0 0 0 0 0 0 0 0 0 7 74 2
2021/2022751 3 3 4 3 290 6 12 23 39 8 50 310
2022/20231.015 160 5 9 27 32 49 3 22 648 5 25 30
2023/2024589 40 12 11 21 264 63 13 6 2 8 31 118
2024/20252.486 16 23 24 38 358 318 213 154 319 755 178 90
2025/20268.125 226 312 443 548 708 4.670 296 439 277 206 0 0
Totale 13.368